Timber Creek Capital Management LLC Amgen Inc Transaction History

Timber Creek Capital Management LLC

$306 Million
Q1 2024

A detailed history of Timber Creek Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Timber Creek Capital Management LLC holds 5,110 shares of AMGN stock, worth $1.69 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

5,110

Previous 5,310 3.77%

Holding current value

$1.69 Million

Previous $1.53 Million 5.04%

% of portfolio

0.47%

Previous 0.55%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 03, 2024	SELL	$268.87 - $324.56 $53,774 - $64,912	-200 Reduced 3.77%	5,110 $1.45 Million
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $572,116 - $726,942	-2,498 Reduced 31.99%	5,310 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $23,568 - $26,580	105 Added 1.36%	7,808 $1.76 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $237,862 - $264,698	-1,031 Reduced 11.8%	7,703 $1.87 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $5,481 - $6,064	-25 Reduced 0.29%	8,734 $2.11 Million

Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $2,983 - $3,414	-15 Reduced 0.17%	8,759 $1.97 Million
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $6,368 - $7,461	-30 Reduced 0.34%	8,774 $1.87 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $16,117 - $17,880	-69 Reduced 0.78%	8,804 $2.15 Million
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $209,704 - $244,377	-945 Reduced 9.63%	8,873 $2.21 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $192,361 - $229,068	-889 Reduced 8.3%	9,818 $2.26 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $266,797 - $296,700	-1,137 Reduced 9.6%	10,707 $2.72 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $933,663 - $1.15 Million	-4,720 Reduced 28.5%	11,844 $2.79 Million
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $79,821 - $105,864	-438 Reduced 2.58%	16,564 $3.36 Million
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $14,569 - $18,726	-77 Reduced 0.45%	17,002 $4.1 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $6,093 - $7,301	-35 Reduced 0.2%	17,079 $3.31 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $12,502 - $14,655	75 Added 0.44%	17,114 $3.15 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $90,254 - $101,736	-499 Reduced 2.85%	17,039 $3.24 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $24,976 - $29,155	-140 Reduced 0.79%	17,538 $3.41 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $7,411 - $8,355	40 Added 0.23%	17,678 $3.66 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $73,726 - $82,810	-444 Reduced 2.46%	17,638 $3.26 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $99,963 - $116,820	-590 Reduced 3.16%	18,082 $3.08 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $48,105 - $53,748	285 Added 1.55%	18,672 $3.25 Million
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $306,977 - $350,485	-1,835 Reduced 9.07%	18,387 $3.43 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-65 Reduced 0.32%	20,222 $3.48 Million
Q2 2017 Aug 11, 2017	BUY	N/A	20,287	20,287 $3.33 Million

Others Institutions Holding AMGN

# of Institutions

2,946

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $177B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Timber Creek Capital Management LLC with notifications on news.

Account

Timber Creek Capital Management LLC Amgen Inc Transaction History